Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis

Charis F. Meng; Diviya A. Rajesh; Deanna P. Jannat-Khah; Bridget Jivanelli; Vivian P. Bykerk

doi:10.3899/jrheum.220152

Research ArticleRheumatoid Arthritis

Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis

Charis F. Meng, Diviya A. Rajesh, Deanna P. Jannat-Khah, Bridget Jivanelli and Vivian P. Bykerk

The Journal of Rheumatology January 2023, 50 (1) 36-47; DOI: https://doi.org/10.3899/jrheum.220152

Charis F. Meng

1C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Charis F. Meng
For correspondence: mengc@hss.edu

Diviya A. Rajesh

2D.A. Rajesh, BA, Division of Rheumatology, Hospital for Special Surgery.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Deanna P. Jannat-Khah

3D.P. Jannat-Khah, DRPH, MSPH, Division of Rheumatology, Epidemiology and Biostatistics CORE, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Deanna P. Jannat-Khah

Bridget Jivanelli

4B. Jivanelli, MLIS, Kim Barrett Memorial Library, HSS Education Institute, Hospital for Special Surgery, New York, NY, USA.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Bridget Jivanelli

Vivian P. Bykerk

1C.F. Meng MD, V.P. Bykerk, MD, Division of Rheumatology, Hospital for Special Surgery, and Department of Medicine, Weill Cornell Medical College.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
ORCID record for Vivian P. Bykerk

Article
Figures & Data
Supplemental
Info & Metrics
References
PDF
eLetters

PreviousNext

Data supplements

DataSuppl

220152DataSuppl.pdf

PreviousNext

In this issue

The Journal of Rheumatology

Vol. 50, Issue 1

1 Jan 2023

Table of Contents
Table of Contents (PDF)
Index by Author
Editorial Board (PDF)

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis

Message Subject (Your Name) has forwarded a page to you from The Journal of Rheumatology

Message Body (Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis

Charis F. Meng, Diviya A. Rajesh, Deanna P. Jannat-Khah, Bridget Jivanelli, Vivian P. Bykerk

The Journal of Rheumatology Jan 2023, 50 (1) 36-47; DOI: 10.3899/jrheum.220152

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Request Permissions

Can Patients With Controlled Rheumatoid Arthritis Taper Methotrexate From Targeted Therapy and Sustain Remission? A Systematic Review and Metaanalysis